B-cell precursor Acute Lymphoblastic Leukemia Minimal Residual Disease (BCP-ALL-MRD)

Organization name

CYTOGNOS, S.L

SRN

ES-MF-000000318

Manufacturer status

Active

4 warnings recorded — scroll inside the panel to see all entries.

• CW076

  EUDAMED did not publish a description for this code.
• CW080

  EUDAMED did not publish a description for this code.
• CW088

  EUDAMED did not publish a description for this code.
• CW106

  EUDAMED did not publish a description for this code.

Primary placement in Spain; available across 32 countries total.

Trade name

B-cell precursor Acute Lymphoblastic Leukemia Minimal Residual Disease (BCP-ALL-MRD)

UDI-DI code

08436548983215

Basic UDI-DI

B-08436548983215

Reference / catalog number

CYT-BCP-ALL-MRD

Issuing entity

GS1

Risk category

IVDD — General

Applicable legislation

IVDD [Directive 98/79/EC on in vitro diagnostic medical devices]

Status

On the market

Quantity

1

Additional product description

The B-Cell Precursor Acute Lymphoblastic Leukemia Minimal Residual Disease (BCP-ALL-MRD) kit is intended for flow-cytometric qualitative and semi-quantitative identification and discrimination of normal/ reactive B-cell precursor (BCP) acute lymphoblastic leukemia (ALL) cells in bone marrow specimens from treated BCP-ALL patients. This reagent must be used by flow cytometry qualified personnel.

Additional information URL

No additional information URL provided by the manufacturer.

Clinical sizes

No clinical sizes registered for this device.

• W0103080699REAGENTS FOR FLOW CYTOMETRY - OTHER

• Batch number
• Expiration date
• Manufacturing date
• Serial number
• Software identification